BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15172629)

  • 21. [LDL apheresis--an effective treatment of homozygous familial hypercholesterolemia].
    Kauppinen-Mäkelin R; Koivisto V; Virtanen KS; Taskinen MR; Miettinen T
    Duodecim; 1990; 106(21):1465-70. PubMed ID: 1364677
    [No Abstract]   [Full Text] [Related]  

  • 22. [LDL apheresis in the treatment of hyperlipoproteinemia].
    Ishikawa K
    Nihon Rinsho; 1994 Dec; 52(12):3298-302. PubMed ID: 7853726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmapheresis in familial hypercholesterolemia.
    Thompson GR; Barbir M; Okabayashi K; Trayner I; Larkin S
    Arteriosclerosis; 1989; 9(1 Suppl):I152-7. PubMed ID: 2912429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosorptive apheresis of LDL.
    Borberg H; Gaczkowski A; Oette K; Stoffel W
    Prog Clin Biol Res; 1990; 337():163-7. PubMed ID: 2191310
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns.
    Koga N
    Ther Apher; 1999 May; 3(2):155-60. PubMed ID: 10341391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of low density lipoprotein apheresis in the treatment of familial hypercholesterolemia.
    Thompson GR; Kitano Y
    Ther Apher; 1997 Feb; 1(1):13-6. PubMed ID: 10225774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LDL-apheresis with the HELP system: a 16-month study in severe hypercholesterolemic patients with ischemic heart disease.
    Baggio G; Previato L; Corti C; Bilato C; Belloni M; Ongaro G; Crepaldi G
    Beitr Infusionsther; 1988; 23():146-51. PubMed ID: 2484770
    [No Abstract]   [Full Text] [Related]  

  • 28. [Radical therapy of refractory hyperlipidemia: extracorporeal cholesterol elimination].
    Kostner KM
    Wien Med Wochenschr; 1994; 144(12-13):333-5. PubMed ID: 8650940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effects of LDL apheresis in the prevention of atherosclerosis.
    Kajinami K; Mabuchi H
    Curr Opin Lipidol; 1999 Oct; 10(5):401-6. PubMed ID: 10554702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Apheresis of low-density lipids in the treatment of hereditary hypercholesterolemia].
    Konovalov GA; Kukharchuk VV; Sinitsin VV; Trakht IN; Adamova IIu
    Vutr Boles; 1989; 28(4):133-6. PubMed ID: 2596087
    [No Abstract]   [Full Text] [Related]  

  • 31. LDL apheresis by dextran sulfate cellulose (DSC) column in two patients with monogenic familial hypercholesterolemia (FH).
    Aubert I; Bombail D; Erlich D; Goussault Y; Rouffy J; Bussel A
    Prog Clin Biol Res; 1990; 337():205-7. PubMed ID: 1693782
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of lipid apheresis in changing times.
    Schuff-Werner P; Fenger S; Kohlschein P
    Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):7-14. PubMed ID: 22911176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hypercholesterolemia with heparin-induced extracorporeal low-density lipoprotein precipitation (HELP).
    Lees RS; Holmes NN; Stadler RW; Ibrahim SF; Lees AM
    J Clin Apher; 1996; 11(3):132-7. PubMed ID: 8915817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporation of low-density lipoprotein apheresis into the treatment program of patients with severe hypercholesterolemia.
    Gordon BR
    Curr Atheroscler Rep; 2000 Jul; 2(4):308-13. PubMed ID: 11122759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The plasmoimmunosorption of low-density lipoproteins in the treatment of patients with hereditary hypercholesterolemia].
    Konovalov GA; Pokrovskiĭ SN; Trakht IN; Bokchubaev E; Volkova EI; Kukharchuk VV
    Ter Arkh; 1991; 63(7):65-70. PubMed ID: 1788813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [LDL-apheresis in the treatment of familial hypercholesterolemia].
    Scarpato N; Postiglione A
    Ric Clin Lab; 1985; 15 Suppl 1():499-504. PubMed ID: 4035229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2alpha.
    Oguogho A; Ferlitsch A; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 2000 Apr; 62(4):209-16. PubMed ID: 10882184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia.
    Schmaldienst S; Banyai S; Stulnig TM; Heinz G; Jansen M; Hörl WH; Derfler K
    Atherosclerosis; 2000 Aug; 151(2):493-9. PubMed ID: 10924726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia.
    Koga N
    Ther Apher; 1997 Aug; 1(3):260-70. PubMed ID: 10225750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Regression of coronary sclerosis in familial hypercholesterolemia IIa by specific LDL apheresis].
    Hombach V; Borberg H; Gadzkowski A; Oette K; Stoffel W
    Dtsch Med Wochenschr; 1986 Nov; 111(45):1709-15. PubMed ID: 3536386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.